Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is leading the next wave of psychedelic drug development beyond mental health with its focus on psilocybin-based treatments for chronic pain and other indications. The company was founded in 2019 and is headquartered in San Diego, California. Innovative Drug Pipeline Tryp’s Psilocybin-for-Neuropsychiatric Disorders (PFN™) program is focused on … Continue reading “Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF)”
Symbol | Release | Time |
---|---|---|
{{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |